RT Journal Article
SR Electronic
T1 Landscape of Gene Mutation in Synovium of Patients with Rheumatoid Arthritis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.14.20064592
DO 10.1101/2020.04.14.20064592
A1 Inamo, Jun
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.14.20064592.abstract
AB Objective To investigate accumulating single nucleotide variants (SNVs) in synovium of patients with early, pre-treatment rheumatoid arthritis (RA).Methods I leveraged RNA-seq dataset derived from patients with RA deposited in database. To capture synovium-specific mutations, I applied standardized SNVs-calling method to paired synovium and blood samples per individual.Results De novo mutational signatures constructed by non-negative matrix factorization reflected continuous relationship of synovial histology, namely lymphoid-myeloid (Lymphoid), diffuse myeloid (Myeloid) and pauci-immune fibroid (Fibroid). Using COSMIC signature, defective DNA damage repair-associated mutational signature was associated with the level of inflammation in synovitis. Further, pathway analysis based on specific genes harboring SNVs in each histological group represent different types of synovitis, with differing pathogenic process and inflammatory environment.Conclusion This data will promote our understandings about pathogenic status of synovitis, and suggests evidence that stratified treatments would be optimal according to histological subgroup.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNothing to declare.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRNA-seq dataset used in the current study is deposited in ArrayExpress under Accession code E-MTAB-6141. Supplementary Table 2-5 are deposited at figshare (https://figshare.com/articles/Supplementary_Tables/11876553). All custom computer codes in the generation or processing of the described data are available upon reasonable request.